{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:45:34Z","timestamp":1778852734370,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.ijcard.2006.06.045","type":"journal-article","created":{"date-parts":[[2006,10,6]],"date-time":"2006-10-06T08:59:46Z","timestamp":1160125186000},"page":"178-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects"],"prefix":"10.1016","volume":"118","author":[{"given":"Zek S.","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony P.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Vettukattil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gruschen R.","family":"Veldtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2006.06.045_bib1","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension","volume":"25","author":"The Task force on diagnosis and treatment of pulmonary arterial hypertension of European society of cardiology","year":"2004","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ijcard.2006.06.045_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00794186","article-title":"Incidence of congenital heart disease: II. Prenatal incidence","volume":"16","author":"Hoffman","year":"1995","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"10.1016\/j.ijcard.2006.06.045_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jama.1967.03120190068008","article-title":"Life expectancy with atrial septal defect. Influence of complicating pulmonary vascular disease","volume":"200","author":"Dalen","year":"1967","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ijcard.2006.06.045_bib4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2003.10.056","article-title":"Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double blind, crossover study","volume":"43","author":"Sastry","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2006.06.045_bib5","doi-asserted-by":"crossref","unstructured":"Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J. 2006 Apr;151(4):851.e1\u20135.","DOI":"10.1016\/j.ahj.2005.09.006"},{"issue":"17","key":"10.1016\/j.ijcard.2006.06.045_bib6","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/01.CIR.0000099502.17776.C2","article-title":"Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension","volume":"108","author":"Evangelos","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcard.2006.06.045_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s002469900502","article-title":"Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15\u00a0year survival: a prospective Bohemia survival study","volume":"20","author":"Samanek","year":"1999","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"10.1016\/j.ijcard.2006.06.045_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/01.CIR.37.5.805","article-title":"Natural history and prognosis of atrial septal defect","volume":"37","author":"Craig","year":"1968","journal-title":"Circulation"},{"issue":"2\u20133","key":"10.1016\/j.ijcard.2006.06.045_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0167-5273(03)00192-X","article-title":"Atrial septal defect in adults > or = 40\u00a0years old: negative impact of low arterial oxygen saturation","volume":"93","author":"Rosas","year":"2004","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ijcard.2006.06.045_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00059-005-2695-4","article-title":"Emerging therapies for the treatment of pulmonary arterial hypertension","volume":"30","author":"Ghofrani","year":"2005","journal-title":"Herz"},{"key":"10.1016\/j.ijcard.2006.06.045_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-1-4419-8997-0_21","article-title":"The NO-K+ channel axis in pulmonary arterial hypertension. Activation by experimental oral therapies","volume":"543","author":"Michelakis","year":"2003","journal-title":"Adv Exp Med Biol"},{"issue":"20","key":"10.1016\/j.ijcard.2006.06.045_bib12","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ijcard.2006.06.045_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ehj.2004.01.013","article-title":"Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects","volume":"25","author":"Mikhail","year":"2004","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ijcard.2006.06.045_bib14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1378\/chest.123.4.1293","article-title":"Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension","volume":"123","author":"Stiebellehner","year":"2003","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.ijcard.2006.06.045_bib15","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/78.10.1207","article-title":"Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy","volume":"78","author":"Bhatia","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.ijcard.2006.06.045_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0735-1097(03)00555-2","article-title":"Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension","volume":"42","author":"Ghofrani","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2006.06.045_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.athoracsur.2004.06.086","article-title":"Oral sildenafil reduces pulmonary hypertension after cardiac surgery","volume":"79","author":"Trachte","year":"2005","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.ijcard.2006.06.045_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1350-9462(02)00013-7","article-title":"Viagra (sildenafil citrate) and ophthalmology","volume":"21","author":"Laties","year":"2002","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.ijcard.2006.06.045_bib19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0161-6420(01)00976-9","article-title":"Sildenafil-associated nonarteritic anterior ischemic optic neuropathy","volume":"109","author":"Pomeranz","year":"2002","journal-title":"Ophthalmology"},{"issue":"5A","key":"10.1016\/j.ijcard.2006.06.045_bib20","doi-asserted-by":"crossref","first-page":"35C","DOI":"10.1016\/S0002-9149(99)00046-6","article-title":"Overall cardiovascular profile of sildenafil citrate","volume":"83","author":"Zusman","year":"1999","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2006.06.045_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2005.05.062","article-title":"Atrial septal defect closure in a patient with \u201cirreversible\u201d pulmonary hypertensive arteriopathy","volume":"110","author":"Schwerzmann","year":"2006","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527306007844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527306007844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:19:26Z","timestamp":1759090766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527306007844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0167527306007844"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2006.06.045","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2006.06.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}